Area of research
Cancer Research · Pulmonary and Respiratory Medicine · protein folding alphafold
Research interest
Research interests include Lung Cancer Treatments and Mutations, MicroRNA in disease regulation, Peptidase Inhibition and Analysis, and RNA modifications and cancer.
DNAJB4/HLJ1 protects against acetaminophen-induced liver injury by attenuating ER stress via HSP70.
IsoPS-DIA: Dual Functionality of Absolute Targeted Quantification and Global Proteome Profiling.
Mapping Nanoscale-To-Single-Cell Phosphoproteomic Landscape by Chip-DIA.
Field-Based, Non-Destructive, and Rapid Detection of Pesticide Residues on Kumquat (Citrus japonica) Surfaces Using Handheld Spectrometer and 1D-ResNet
Integrative analysis of lung adenocarcinoma across diverse ethnicities and exposures
Tp53 determines the spatial dynamics of M1/M2 tumor-associated macrophages and M1-driven tumoricidal effects.
OCIAD2 Promotes Cancer Progression via Metabolic Reprogramming in Lung Adenocarcinoma.
Tumor suppression through the interaction between CNTN4 and PTPRG attenuates EGFR signaling in colorectal cancer
Tissue Proteogenomic Landscape Reveals the Role of Uncharacterized SEL1L3 in Progression and Immunotherapy Response in Lung Adenocarcinoma.
The Ring Study: an international comparison of PD-L1 diagnostic assays and their interpretation in non-small cell lung cancer, head and neck squamous cell cancer and urothelial cancer.
LCRMP-1 is required for spermatogenesis and stabilises spermatid F-actin organization via the PI3K-Akt pathway.
Reduced symmetric dimethylation stabilizes vimentin and promotes metastasis in MTAP-deficient lung cancer.
PCDH10 exerts tumor-suppressor functions through modulation of EGFR/AKT axis in colorectal cancer.
Prognostic Characteristics and Immunotherapy Response of Patients With Nonsquamous NSCLC With <i>Kras</i> Mutation in East Asian Populations: A Single-Center Cohort Study in Taiwan.
Genome-Wide Epigenetic Landscape of Lung Adenocarcinoma Links HOXB9 DNA Methylation to Intrinsic EGFR-TKI Resistance and Heterogeneous Responses.
The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M.
Primary Tumor Radiotherapy During EGFR-TKI Disease Control Improves Survival of Treatment Naïve Advanced EGFR-Mutant Lung Adenocarcinoma Patients.
Primary Tumor Resection Is Associated with a Better Outcome among Advanced EGFR-Mutant Lung Adenocarcinoma Patients Receiving EGFR-TKI Treatment.
IKKε isoform switching governs the immune response against EV71 infection.
Transthyretin as a Biomarker to Predict and Monitor Major Depressive Disorder Identified by Whole-Genome Transcriptomic Analysis in Mouse Models.
Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia with kinase fusions in Taiwan.
The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study.
Publisher Correction: The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M.
Machine Learning Reveals the Unique Biomarkers of Clonal Hematopoiesis in Patient With Early-Stage Colorectal Neoplasia: A Case Control Study
Proteogenomics of Non-smoking Lung Cancer in East Asia Delineates Molecular Signatures of Pathogenesis and Progression.
ALK variants, PD-L1 expression, and their association with outcomes in ALK-positive NSCLC patients.
A Celecoxib Derivative Eradicates Antibiotic-Resistant <i>Staphylococcus aureus</i> and Biofilms by Targeting YidC2 Translocase.
FPGS relapse-specific mutations in relapsed childhood acute lymphoblastic leukemia.
Landscape of Mitochondria Genome and Clinical Outcomes in Stage 1 Lung Adenocarcinoma.
Statin-induced microRNAome alterations modulating inflammation pathways of peripheral blood mononuclear cells in patients with hypercholesterolemia.